TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12672714

Group type: COMPARATOR
Intervention: Baseline (BL) diet (35% fat, 14% SFA, 13% MUFA, 8% PUFA, 147 mg cholesterol/1000 kcal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Reduced-fat (RF) diet (26% fat, 4% SFA, 11% MUFA, 11% PUFA, 45 mg cholesterol/1000 kcal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-fat (LF) diet (15% fat, 5% SFA, 5% MUFA, 3% PUFA, 35 mg cholesterol/1000 kcal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-fat calorie reduced (LFCR) diet
Number of subjects: 10
Study: 10929448

Group type: EXPERIMENTAL
Intervention: Traditional needle placement and manipulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Needles placed away from classic positions and not manipulated (Control)
Number of subjects: 67
Study: 8827134

Group type: EXPERIMENTAL
Intervention: Complex decision rules with feedback at 22 degrees C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Complex decision rules with feedback at 40 degrees C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Feedback in decision-making tasks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Heat stress (40 degrees C)
Number of subjects: 22
Study: 1418778

Group type: EXPERIMENTAL
Intervention: Zidovudine (250 mg every 6 h)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Zidovudine + Acyclovir (800 mg every 6 h)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 6396834

Group type: EXPERIMENTAL
Intervention: Single-dose trimethoprim-sulfamethoxazole (4 tablets)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: 3-day trimethoprim-sulfamethoxazole (2 tablets twice daily)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: 10-day trimethoprim-sulfamethoxazole (2 tablets twice daily)
Number of subjects: 464
Study: 30951148

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation 600 IU/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation 2,000 IU/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation 4,000 IU/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29386058

Group type: EXPERIMENTAL
Intervention: Art integration using Caravaggio's paintings during the Ramsay sedation score lesson
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard lesson without artistic support
Number of subjects: 22
Study: 26466321

Group type: EXPERIMENTAL
Intervention: Bioimpedance intervention group with increased dialysate glucose prescription
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control group (anuric patients in Shanghai)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Nonanuric BI intervention group (UK)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Active and control anuric patients (multilevel analysis)
Number of subjects: 308
Study: 24480836

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with tramadol and ketamine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (tramadol and ketamine)
Number of subjects: 75
Study: 22875560

Group type: EXPERIMENTAL
Intervention: Yoga and exercise (YEX)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Exercise only (EX)
Number of subjects: 14
Study: 20052573

Group type: EXPERIMENTAL
Intervention: Vaginal weight cone (VWC)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Assisted pelvic floor muscle training (APFMT)
Number of subjects: 103
Study: 18759805

Group type: EXPERIMENTAL
Intervention: Intervention to structure patient-key worker communication
Number of subjects: 507
Study: 15979851

Group type: EXPERIMENTAL
Intervention: Closed reduction (CR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 45
Study: 12534381

Group type: EXPERIMENTAL
Intervention: Paraffin tulle gras (PTG) dressing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonadherent absorbable (NAA) dressing
Number of subjects: 50
Study: 9501747

Group type: EXPERIMENTAL
Intervention: Paroxetine (33.9 mg daily)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Imipramine (162.5 mg daily)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 7663312

Group type: EXPERIMENTAL
Intervention: ritanserin 5 mg/day
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ritanserin 10 mg/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study: 2624911

Group type: EXPERIMENTAL
Intervention: Keta tonometer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Goldmann tonometer
Number of subjects: 60
Study: 630965

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (two large doses administered intravenously)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 29
Study: 30739259

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy (PAC) > 3 cycles
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy (PAC) 1-3 cycles
Number of subjects: 401
Study: 29368207

Group type: EXPERIMENTAL
Intervention: High cognitive and interpersonal risk group
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Low cognitive and interpersonal risk group
Number of subjects: 467
Study: 27655012

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) infusion (0.5 μg/kg per min for 4 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25641309

Group type: EXPERIMENTAL
Intervention: Low-load motor control (LMC) exercise
Number of subjects: 70

Group type: COMPARATOR
Intervention: High-load lifting (HLL) exercise
Number of subjects: 70
Study: 23592833

Group type: EXPERIMENTAL
Intervention: CRT defibrillator
Number of subjects: 111

Group type: COMPARATOR
Intervention: Dual-chamber implantable cardioverter-defibrillator
Number of subjects: 111
Study: 20579960

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 177
Study: 17925335

Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 16669955

Group type: EXPERIMENTAL
Intervention: 120 mg alicaforsen
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: 240 mg alicaforsen
Number of subjects: 159

Group type: COMPARATOR
Intervention: mesalazine
Number of subjects: 159
Study: 12783912

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 25 mg once daily
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Naproxen, 220 mg twice daily
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 10745280

Group type: EXPERIMENTAL
Intervention: Designer eggs enriched in vitamin E, lutein, selenium (Se), and docosahexaenoic acid (DHA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal table eggs
Number of subjects: 40
Study: 8931866

Group type: EXPERIMENTAL
Intervention: PAMBA 100-200 mg daily for 7 to 26 days with moderate corticosteroids (mean dose 36.1 mg prednisolone equivalent)
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-dose corticosteroids (mean 94.2 mg prednisolone equivalent) and immunosuppressive drugs
Number of subjects: 24
Study: 1552109

Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 500

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Ioxaglate with diphenhydramine premedication
Number of subjects: 500

Group type: COMPARATOR
Intervention: Iopamidol with diphenhydramine premedication
Number of subjects: 500
Study: 2996580

Group type: EXPERIMENTAL
Intervention: Nedocromil (2 mg) by inhalation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31021023

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) IL-6 levels in neurosarcoidosis patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CSF CD4/CD8 ratio in neurosarcoidosis patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CSF IL-6 levels in active vs. non-active neurosarcoidosis patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CSF IL-6 concentration >50 pg/ml in neurosarcoidosis patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Anti-IL-6 monoclonal antibody treatment in a refractory neurosarcoidosis patient
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CSF IL-10 levels in neurosarcoidosis patients
Number of subjects: 43
Study: 30312310

Group type: EXPERIMENTAL
Intervention: Running-related injuries (RRI)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Medial tibial stress syndrome (MTSS)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Achilles tendinopathy (AT)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Patellofemoral pain (PFP)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: All types of injuries
Number of subjects: 140
Study: 27004719

Group type: EXPERIMENTAL
Intervention: Smartwatch
Number of subjects: 10

Group type: COMPARATOR
Intervention: Smartphone
Number of subjects: 10
Study: 25972024

Group type: EXPERIMENTAL
Intervention: Sustained eradication of Pseudomonas aeruginosa (Pa) after early antipseudomonal therapy
Number of subjects: 249

Group type: COMPARATOR
Intervention: Nonsustained eradication of Pseudomonas aeruginosa (Pa) after early antipseudomonal therapy
Number of subjects: 249
Study: 23392477

Group type: EXPERIMENTAL
Intervention: Intraoperative bile leakage test (sterile fat emulsion injected through the duct of the gallbladder)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conventional methods for treating the hepatic resection plane
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Intraoperative bile leakage test
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 107
Study: 20435999

Group type: EXPERIMENTAL
Intervention: Standard NexGen CR‐flex prosthesis
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gender-specific NexGen CR‐flex prosthesis
Number of subjects: 138

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 138
Study: 18541884

Group type: EXPERIMENTAL
Intervention: NGX‐4010 (high-concentration capsaicin patch)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: NGX‐4010 (30-minute application)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: NGX‐4010 (60-minute application)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: NGX‐4010 (90-minute application)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control (low-concentration capsaicin patch)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: NGX‐4010
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control
Number of subjects: 307
Study: 16028530

Group type: EXPERIMENTAL
Intervention: Recombinant IFN‐alpha2 with complex immunoglobulin preparation (CIP) via rectal method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant IFN‐alpha2 with complex immunoglobulin preparation (CIP) via inhalation method
Number of subjects: 0
Study: 12759839

Group type: EXPERIMENTAL
Intervention: Acrylic intraocular lenses
Number of subjects: 0

Group type: COMPARATOR
Intervention: PMMA intraocular lenses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silicone intraocular lenses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin coated PMMA intraocular lenses
Number of subjects: 0
Study: 10078608

Group type: EXPERIMENTAL
Intervention: Tetanus vaccination (Td) with primaquine prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetanus vaccination (Td) with placebo prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetanus vaccination (Td) with chloroquine prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nonimmunized)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid (TT) at low concentration (0.1 microg ml(‐1))
Number of subjects: 0
Study: 7672149

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection with vigorous aspiration of oocyte cytoplasm
Number of subjects: 100
Study: 3064266

Group type: EXPERIMENTAL
Intervention: Breast preservation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 0
Study: 29687620

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.5 mg
Number of subjects: 3900

Group type: EXPERIMENTAL
Intervention: Semaglutide 1.0 mg
Number of subjects: 3900

Group type: COMPARATOR
Intervention: Semaglutide
Number of subjects: 3900
Study: 28841431

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (target SBP: 120 mmHg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard blood pressure treatment (target SBP: 140 mmHg)
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Low diastolic blood pressure (< 60 mmHg)
Number of subjects: 9361
Study: 26226440

Group type: EXPERIMENTAL
Intervention: Doripenem
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 66
Study: 24130735

Group type: EXPERIMENTAL
Intervention: Placebo-suggestion (positive suggestion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo-suggestion (negative suggestion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-hypnotic imaginative suggestion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 0
Study: 21418841

Group type: EXPERIMENTAL
Intervention: Modified Nissen fundoplication after esophagogastrostomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Esophagogastrostomy with stapler only (Control group)
Number of subjects: 70
Study: 18923231

Group type: EXPERIMENTAL
Intervention: Celacade therapy
Number of subjects: 0
Study: 20389253

Group type: EXPERIMENTAL
Intervention: LASIK surgery
Number of subjects: 20
Study: 16139717

Group type: EXPERIMENTAL
Intervention: Fluoride-containing cement
Number of subjects: 90

Group type: COMPARATOR
Intervention: Palacos with gentamicin (Control)
Number of subjects: 90
Study: 11925376

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (multiple low-dose 0.25 mg and single high-dose 3 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: GnRH antagonist and GnRH agonist (long protocol)
Number of subjects: 0
Study: 9593172

Group type: EXPERIMENTAL
Intervention: WR 238605, a single oral dose of 600 mg administered 1 day prior to challenge
Number of subjects: 4
Study: 8169182

Group type: EXPERIMENTAL
Intervention: Clonazepam (CZP) up to 2 mg/day for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Clonazepam (CZP)
Number of subjects: 15
Study: 3198992

Group type: EXPERIMENTAL
Intervention: Ketanserin (10 mg IV as bolus)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12215318

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29030710

Group type: EXPERIMENTAL
Intervention: Bipolar hip arthroplasty (BHA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Total hip replacement (THR)
Number of subjects: 42
Study: 26577691

Group type: EXPERIMENTAL
Intervention: Azacitidine (AZA) monotherapy (50 mg/m²/day for 10 days)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Azacitidine (AZA) + Entinostat (4 mg/m²/day on days 3 and 10)
Number of subjects: 47
Study: 25034515

Group type: EXPERIMENTAL
Intervention: Timed artificial insemination (TAI) protocol starting at 12 days after P4 device removal
Number of subjects: 774

Group type: COMPARATOR
Intervention: Timed artificial insemination (TAI) protocol starting at 10 days after P4 device removal
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Timed artificial insemination (TAI) protocol starting at 14 days after P4 device removal
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Final pregnancy rate across all groups
Number of subjects: 774
Study: 22378225

Group type: EXPERIMENTAL
Intervention: Carbohydrates (2% of energy intake) replacing fat
Number of subjects: 25943

Group type: EXPERIMENTAL
Intervention: Carbohydrates (2% of energy intake) replacing protein
Number of subjects: 25943

Group type: EXPERIMENTAL
Intervention: Medium-GI carbohydrates replacing total fat
Number of subjects: 25943

Group type: EXPERIMENTAL
Intervention: Low-, medium-, or high-GI carbohydrates replacing total, meat, or milk protein
Number of subjects: 25943
Study: 20152561

Group type: EXPERIMENTAL
Intervention: Clopidogrel tapering regimen for 4 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Continued daily clopidogrel intake for 4 more weeks
Number of subjects: 69
Study: 18805757

Group type: EXPERIMENTAL
Intervention: Amphotericin B nasal spray (5 mg/ml)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo nasal spray (lacking amphotericin B)
Number of subjects: 30
Study: 16136470

Group type: EXPERIMENTAL
Intervention: Single-dose nevirapine
Number of subjects: 32
Study: 12186600

Group type: EXPERIMENTAL
Intervention: Ginkgo, 40 mg 3 times per day (n = 115)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo (n = 115)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Ginkgo
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 10540009

Group type: EXPERIMENTAL
Intervention: Mouth Occlusion Pressure (MOP)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Exercise Testing (ET)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Maximal Inspiratory Pressure (PI(max))
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Peak Expiratory Pressure (PE(max))
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Norris Spinal Score (SNS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Bulbar Score (BNS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MOP slope
Number of subjects: 28
Study: 7599728

Group type: EXPERIMENTAL
Intervention: One-stage surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Two-stage surgery
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: One-stage surgery (subsequent consecutive group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall one-stage surgeries
Number of subjects: 44

Group type: COMPARATOR
Intervention: Overall two-stage surgeries
Number of subjects: 44
Study: 2092029

Group type: EXPERIMENTAL
Intervention: famotidine 40 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: ranitidine 300 mg
Number of subjects: 40
Study: 897855

Group type: EXPERIMENTAL
Intervention: Atropine 0.5 mg injected intramuscularly half an hour before the meal
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg injected intramuscularly half an hour before the meal
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 63
Study: 31091322

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EAc)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sham Electroacupuncture (ShEAc)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 52
Study: 31337342

Group type: EXPERIMENTAL
Intervention: Gemcitabine 900 mg/m2 on Days 1 and 8, and docetaxel 70 mg/m2 on Day 8 in 3-week cycles until disease progression or treatment failure.
Number of subjects: 20
Study: 28168925

Group type: EXPERIMENTAL
Intervention: Red Bull energy drink 250 mL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Red Bull Sugarfree energy drink 250 mL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo 250 mL
Number of subjects: 24
Study: 25639864

Group type: EXPERIMENTAL
Intervention: Surgery followed by adjuvant radiotherapy (S arm)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) (C arm)
Number of subjects: 119
Study: 23992525

Group type: EXPERIMENTAL
Intervention: Full-mouth periodontal scaling and root planing during a single visit
Number of subjects: 273

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 273
Study: 21555229

Group type: EXPERIMENTAL
Intervention: Educational intervention with graphic material for postoperative pain management
Number of subjects: 497

Group type: COMPARATOR
Intervention: Control group with standard training on surgical and postoperative recommendations
Number of subjects: 497
Study: 19636715

Group type: EXPERIMENTAL
Intervention: Racial rejection images
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nonracial positive images
Number of subjects: 35

Group type: COMPARATOR
Intervention: Racial acceptance images
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nonracial negative images
Number of subjects: 35
Study: 16396865

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) group (> or =30 seconds from moment of delivery)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) group with conventional management
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) for vaginal deliveries
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) for cesarean deliveries
Number of subjects: 46
Study: 12694429

Group type: EXPERIMENTAL
Intervention: NK 10% gel
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: NK 5% gel
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 45
Study: 11028477

Group type: EXPERIMENTAL
Intervention: 10 microg/kg of bFGF
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 30 microg/kg of bFGF once
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 30 microg/kg of bFGF on two consecutive days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 8870539

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medications
Number of subjects: 0
Study: 1643700

Group type: EXPERIMENTAL
Intervention: Intravenous idarubicin (12 mg/m2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oral idarubicin (30-35 mg/m2)
Number of subjects: 21
Study: 6433636

Group type: EXPERIMENTAL
Intervention: Aspirin (median dose 31 mg/kg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29086030

Group type: EXPERIMENTAL
Intervention: New equations for predicting resting energy expenditure (REE) developed from Group 1 (n=174)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: New equations for predicting resting energy expenditure (REE) generated from Group 2 (n=115)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Cross-validation of equations using Group 3 (n=41)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Comparison with other REE prediction equations
Number of subjects: 330